Skip To Main Content
Joyce N Barlin on Muck Rack

Joyce N Barlin

As seen in: Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Joyce N

Contact Joyce N, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

ARTISTRY-7: Phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer

|
By Thomas Herzog, John L. Hays, Joyce N Barlin, Joseph Buscema
| Future Medicine Verified
Future OncologyAhead of Print Clinical Trial ProtocolOpen Access On behalf of the ARTISTRY-7 Study Team , , , , , , , , , , , , , , , , , , , , & Abstract Standard single-agent nonplatinum chemotherapy provides only modest benefit in a small proportion of patients with platinum-resistant/-refractory ovarian cancer, with objective response rates of 6–20% and progression-free survival of ≈3–4 months.
Open in Who Shared Issue with article?
See all 1 articles